Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
The Lancet. Oncology
|
January 5, 2025
Evidence for a reduction in number of cycles of immune checkpoint inhibitors
Abdul-Hamid Bazarbachi, Nicola Magrini, Zeba Aziz, et al.
Japanese Journal of Clinical Oncology
|
March 2, 2010
Sustained superior long-term outcomes and cytogenetic responses with imatinib mesylate in chronic phase chronic myeloid leukaemia: report from a developing country
Zeba Aziz, Javaid Iqbal, Kausar Bano, et al.
JCO Global Oncology
|
September 5, 2024
ASCO Global Guidelines: Methods and Opportunities
Zeba Aziz, Sarah Temin, Sarah Bachmann, et al.
Leukemia & Lymphoma
|
November 19, 2013
Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country
Javaid Iqbal, Zafar Ali, Aruj-Un-Nisa Khan, et al.
Leukemia & Lymphoma
|
May 4, 2011
Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia
Zeba Aziz, Javaid Iqbal, Muhammad Aaqib, et al.
JPMA. the Journal of the Pakistan Medical Association
|
March 9, 2011
Survival of women with locally advanced breast cancer at a teaching hospital in Lahore
Javaid Iqbal, Kausar Bano, Asif Saeed, et al.
American Journal of Clinical Oncology
|
April 26, 2003
Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder
Imtiaz A Malik, Zeba Aziz, S H Manzoor Zaidi, et al.
Journal of the American Geriatrics Society
|
September 22, 2015
A Survey of Concerns in End-of-Life Care: Perspective from Pakistan
Ariba Khan, Maharaj Singh, Sarah Saeed, et al.
Cancer
|
October 7, 2008
Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries
Nagi S El Saghir, Alexandru Eniu, Robert W Carlson, et al.
American Journal of Human Genetics
|
August 16, 2002
Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
Alexander Liede, Imtiaz A Malik, Zeba Aziz, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
The Lancet. Oncology
|
January 5, 2025
Evidence for a reduction in number of cycles of immune checkpoint inhibitors
Abdul-Hamid Bazarbachi, Nicola Magrini, Zeba Aziz, et al.
Japanese Journal of Clinical Oncology
|
March 2, 2010
Sustained superior long-term outcomes and cytogenetic responses with imatinib mesylate in chronic phase chronic myeloid leukaemia: report from a developing country
Zeba Aziz, Javaid Iqbal, Kausar Bano, et al.
JCO Global Oncology
|
September 5, 2024
ASCO Global Guidelines: Methods and Opportunities
Zeba Aziz, Sarah Temin, Sarah Bachmann, et al.
Leukemia & Lymphoma
|
November 19, 2013
Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country
Javaid Iqbal, Zafar Ali, Aruj-Un-Nisa Khan, et al.
Leukemia & Lymphoma
|
May 4, 2011
Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia
Zeba Aziz, Javaid Iqbal, Muhammad Aaqib, et al.
JPMA. the Journal of the Pakistan Medical Association
|
March 9, 2011
Survival of women with locally advanced breast cancer at a teaching hospital in Lahore
Javaid Iqbal, Kausar Bano, Asif Saeed, et al.
American Journal of Clinical Oncology
|
April 26, 2003
Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder
Imtiaz A Malik, Zeba Aziz, S H Manzoor Zaidi, et al.
Journal of the American Geriatrics Society
|
September 22, 2015
A Survey of Concerns in End-of-Life Care: Perspective from Pakistan
Ariba Khan, Maharaj Singh, Sarah Saeed, et al.
Cancer
|
October 7, 2008
Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries
Nagi S El Saghir, Alexandru Eniu, Robert W Carlson, et al.
American Journal of Human Genetics
|
August 16, 2002
Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
Alexander Liede, Imtiaz A Malik, Zeba Aziz, et al.
Page
of 5